Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
Clinical trial NCT06574503 · RECRUITING
Trial details
- NCT number
- NCT06574503
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2027-07-30
- Enrollment
- 748
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.